| Related Articles |
T-DM1 for residual, invasive, HER2-positive breast cancer.
Lancet Oncol. 2018 Dec 13;:
Authors: Burki TK
PMID: 30555022 [PubMed - as supplied by publisher]
from A via a.sfakia on Inoreader https://ift.tt/2SVKZiu
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
| Related Articles |
T-DM1 for residual, invasive, HER2-positive breast cancer.
Lancet Oncol. 2018 Dec 13;:
Authors: Burki TK
PMID: 30555022 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,